CYPHERPUNK TECHNOLOGIES INC. Retained Earnings
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Retained Earnings of -$500.33 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$500.33M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$539.72M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$462.55M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$502.75M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$500.33M 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$539.72M 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$462.55M 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$502.75M 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$499.45M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$482.81M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$467.37M 10-K · filed 2026-03-16 |
| 2024-09-30 | -$451.94M 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$433.76M 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$413.40M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$399.58M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$387.12M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$373.42M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$360.03M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$318.17M 10-K · filed 2024-03-18 |
| 2022-09-30 | -$306.07M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$290.97M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$273.95M 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$263.57M 10-K · filed 2023-03-24 |
| 2021-09-30 | -$252.78M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$241.65M 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$232.12M 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$222.99M 10-K · filed 2022-03-11 |
| 2020-09-30 | -$216.28M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$209.22M 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$202.70M 10-Q · filed 2020-05-14 |
| 2019-12-31 | -$195.17M 10-K · filed 2021-03-12 |
| 2019-09-30 | -$187.17M 10-Q · filed 2019-11-14 |
| 2019-06-30 | -$179.24M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$170.87M 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$153.53M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$155.01M 10-Q · filed 2018-11-09 |
| 2018-06-30 | -$148.38M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$141.02M 10-Q/A · filed 2018-08-08 |
| 2017-12-31 | -$130.40M 10-K · filed 2019-04-01 |
| 2017-09-30 | -$123.80M 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$116.99M 10-Q · filed 2017-08-11 |
| 2017-03-31 | -$110.08M 10-Q · filed 2017-05-12 |
| 2016-12-31 | -$100.67M 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |